XML 8 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2024
Aug. 19, 2024
USD ($)
shares
$ / shares
Rate
Mar. 01, 2024
USD ($)
shares
$ / shares
Rate
Award Timing Disclosures [Line Items]      
Award Timing MNPI Disclosure

Practices Related to the Grant of Certain Equity Awards

In accordance with Item 402(x) of Regulation S-K, we are providing information regarding our practices related to the grant of stock options close in time to the release of material non-public information. As described above, it is not our policy to time the release of material nonpublic information for the purpose of affecting the value of executive compensation or to take material nonpublic information into account when determining the timing and terms of such awards. Although we do not have a formal policy with respect to the timing of our annual equity award grants, our board of directors or compensation committee has historically granted such awards on a predetermined annual schedule, which includes annual equity awards approved during the first quarter and granted on the first business day of March of each year. Equity grants may also be made on other dates in connection with new hires, promotions, or similar events, and are typically made on the first business day of the month following the employees start date, unless a different date is approved by our compensation committee.

The grant of annual stock option awards for 2024 to Dr. McArthur and Mr. Donnelly was made consistent with the timing of prior year’s annual grants, the first business day of March, but occurred within four business days before we filed the 2024

Annual Report on March 6, 2024. The new hire stock option award for Dr. Streck was made on his start date of August 19, 2024, consistent with other new hire awards to executive officers, but occurred within four business days before we filed a Current Report on Form 8-K under Item 8.01 on August 20, 2024 reporting our announcement that we had hired Dr. Streck. 		   
Award Timing Method Although we do not have a formal policy with respect to the timing of our annual equity award grants, our board of directors or compensation committee has historically granted such awards on a predetermined annual schedule, which includes annual equity awards approved during the first quarter and granted on the first business day of March of each year. Equity grants may also be made on other dates in connection with new hires, promotions, or similar events, and are typically made on the first business day of the month following the employees start date, unless a different date is approved by our compensation committee.    
Award Timing Predetermined true    
Award Timing MNPI Considered true    
Award Timing, How MNPI Considered As described above, it is not our policy to time the release of material nonpublic information for the purpose of affecting the value of executive compensation or to take material nonpublic information into account when determining the timing and terms of such awards.    
MNPI Disclosure Timed for Compensation Value true    
James McArthur, Ph.D.      
Awards Close in Time to MNPI Disclosures      
Name     James McArthur, Ph.D.
Underlying Securities | shares     300,000
Exercise Price | $ / shares     $ 16.62
Fair Value as of Grant Date | $     $ 11.93
Underlying Security Market Price Change | Rate     (14.70%)
Noel Donnelly, M.B.A.      
Awards Close in Time to MNPI Disclosures      
Name     Noel Donnelly, M.B.A.
Underlying Securities | shares     144,000
Exercise Price | $ / shares     $ 16.62
Fair Value as of Grant Date | $     $ 11.93
Underlying Security Market Price Change | Rate     (14.70%)
Paul Streck, M.D., M.B.A.      
Awards Close in Time to MNPI Disclosures      
Name   Paul Streck, M.D., M.B.A.  
Underlying Securities | shares   242,816  
Exercise Price | $ / shares   $ 9.83  
Fair Value as of Grant Date | $   $ 7.16  
Underlying Security Market Price Change | Rate   0.20%